SavedAdd your journal

Journals / Clinical and Experimental Health Sciences / 2022 / Cilt: 12 - Sayı: 2

The Role of Omega-3 and Antioxidant Nutrients in Age-Related Macular Degeneration: A Review Article

Emine KOÇYİĞİT
Nilüfer ACAR TEK
Pages
548–555
Publication Date
2022-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, the relationship between omega 3 and antioxidant nutrients and the incidence and progression of AMD were evaluated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss worldwide.
📊
Key Findings & Data:Various results of studies suggest that omega-3 fatty acids may have beneficial effects in AMD.
💡
Conclusion & Impact:In this study, the relationship between omega 3 and antioxidant nutrients and the incidence and progression of AMD were evaluated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:age-related macular degeneration · omega 3 fatty acids · nutrition

Abstract

Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss worldwide. The cause of the disease is not well explained; studies previse a multifactorial etiology. Various results of studies suggest that omega-3 fatty acids may have beneficial effects in AMD. Besides the omega-3, clinical evidence showed that specific micronutrients (antioxidant vitamins and minerals) protect against AMD. The definition of risk factors for the development and progression of AMD is important for understanding the causes of the disorder and for the determination of its prevention strategies. In this study, the relationship between omega 3 and antioxidant nutrients and the incidence and progression of AMD were evaluated.

🔖

Cite This Article

KOÇYİĞİT, E., TEK, N. A. (2022). The Role of Omega-3 and Antioxidant Nutrients in Age-Related Macular Degeneration: A Review Article. Clinical and Experimental Health Sciences, Cilt: 12 - Sayı: 2, 548–555. https://ajindex.com/articles/481133

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, De Jong P, Nemesure B, Mitchell P, Kempen J. Prevalence of age-related macular degeneration in the United States. Arch ophthalmol 2004;122(4):564-572
  2. Ratnapriya R, Chew EY. Age-related macular degeneration— clinical review and genetics update. Clin Genet 2013;84(2):160- 166
  3. Pennington KL, DeAngelis MM. Epidemiology of age related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond) 2016;3(1):34
  4. Wong WL, Su X, Li X, Cheung CMG, Klein R., Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014;2(2):e106-e116
  5. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96(5):614-618
  6. Al Gwairi O, Thach L, Zheng W, Osman N, Little PJ. Cellular and molecular pathology of age-related macular degeneration: potential role for proteoglycans. J Ophthalmol 2016;2016:2913612
  7. Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A. Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet 2014;15:151-171
  8. Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age related macular degeneration—emerging pathogenetic and therapeutic concepts. Ann Med 2006;38(7):450-471
  9. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med 2008;358(24):2606-2617
  10. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007;114(2):253-262
  11. Arroyo JG. Age-related macular degeneration: Treatment and prevention. UpToDate, Waltham, MA 2020;1(1):1-12
  12. Aslam T, Delcourt C, Silva R, Holz FG, Leys A, Layana AG, Souied E. Micronutrients in age-related macular degeneration. Ophthalmologica 2013;229(2):75-79
  13. Age-Related Eye Disease Study (AREDS) Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no
  14. Arch Ophthalmol 2001;119(10):1417
  15. Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoidsand risk of age-related maculopathy. Arch Ophthalmol 2004;122(6)